Copyright Reports & Markets. All rights reserved.

Global Drug of Abuse (DOA) Testing Equipment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Drug of Abuse (DOA) Testing Equipment Industry
  • 1.7 COVID-19 Impact: Drug of Abuse (DOA) Testing Equipment Market Trends

    • 2 Global Drug of Abuse (DOA) Testing Equipment Quarterly Market Size Analysis

    • 2.1 Drug of Abuse (DOA) Testing Equipment Business Impact Assessment - COVID-19
      • 2.1.1 Global Drug of Abuse (DOA) Testing Equipment Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Drug of Abuse (DOA) Testing Equipment Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Drug of Abuse (DOA) Testing Equipment Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Drug of Abuse (DOA) Testing Equipment Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Drug of Abuse (DOA) Testing Equipment Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Drug of Abuse (DOA) Testing Equipment Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Drug of Abuse (DOA) Testing Equipment Market
    • 3.5 Key Manufacturers Drug of Abuse (DOA) Testing Equipment Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Drug of Abuse (DOA) Testing Equipment Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Immunoassay analyzers
      • 1.4.2 Chromatography instruments
      • 1.4.3 Breath analyzers
      • 1.4.4 Others
    • 4.2 By Type, Global Drug of Abuse (DOA) Testing Equipment Market Size, 2019-2021
      • 4.2.1 By Type, Global Drug of Abuse (DOA) Testing Equipment Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Drug of Abuse (DOA) Testing Equipment Price, 2020-2021

    5 Impact of Covid-19 on Drug of Abuse (DOA) Testing Equipment Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Laboratories
      • 5.5.3 Workplace
      • 5.5.4 At-Home
    • 5.2 By Application, Global Drug of Abuse (DOA) Testing Equipment Market Size, 2019-2021
      • 5.2.1 By Application, Global Drug of Abuse (DOA) Testing Equipment Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Drug of Abuse (DOA) Testing Equipment Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Siemens AG
      • 7.1.1 Siemens AG Business Overview
      • 7.1.2 Siemens AG Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.1.3 Siemens AG Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.1.4 Siemens AG Response to COVID-19 and Related Developments
    • 7.2 Merck
      • 7.2.1 Merck Business Overview
      • 7.2.2 Merck Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.2.3 Merck Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.2.4 Merck Response to COVID-19 and Related Developments
    • 7.3 Roche
      • 7.3.1 Roche Business Overview
      • 7.3.2 Roche Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.3.3 Roche Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.3.4 Roche Response to COVID-19 and Related Developments
    • 7.4 Thermo Fisher Scientific
      • 7.4.1 Thermo Fisher Scientific Business Overview
      • 7.4.2 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.4.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
    • 7.5 Bio-Rad
      • 7.5.1 Bio-Rad Business Overview
      • 7.5.2 Bio-Rad Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.5.3 Bio-Rad Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.5.4 Bio-Rad Response to COVID-19 and Related Developments
    • 7.6 Abbott
      • 7.6.1 Abbott Business Overview
      • 7.6.2 Abbott Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.6.3 Abbott Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.6.4 Abbott Response to COVID-19 and Related Developments
    • 7.7 Quest Diagnostics
      • 7.7.1 Quest Diagnostics Business Overview
      • 7.7.2 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.7.4 Quest Diagnostics Response to COVID-19 and Related Developments
    • 7.8 Express Diagnostics Int'l
      • 7.8.1 Express Diagnostics Int'l Business Overview
      • 7.8.2 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.8.3 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.8.4 Express Diagnostics Int'l Response to COVID-19 and Related Developments
    • 7.9 Psychemedics
      • 7.9.1 Psychemedics Business Overview
      • 7.9.2 Psychemedics Drug of Abuse (DOA) Testing Equipment Quarterly Production and Revenue, 2020
      • 7.9.3 Psychemedics Drug of Abuse (DOA) Testing Equipment Product Introduction
      • 7.9.4 Psychemedics Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Drug of Abuse (DOA) Testing Equipment Supply Chain Analysis
      • 8.1.1 Drug of Abuse (DOA) Testing Equipment Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Drug of Abuse (DOA) Testing Equipment Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Drug of Abuse (DOA) Testing Equipment Distribution Channels
      • 8.2.2 Covid-19 Impact on Drug of Abuse (DOA) Testing Equipment Distribution Channels
      • 8.2.3 Drug of Abuse (DOA) Testing Equipment Distributors
    • 8.3 Drug of Abuse (DOA) Testing Equipment Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Drug of Abuse (DOA) Testing Equipment, including the following market information:
      Global Drug of Abuse (DOA) Testing Equipment Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Drug of Abuse (DOA) Testing Equipment Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Drug of Abuse (DOA) Testing Equipment Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Drug of Abuse (DOA) Testing Equipment Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Siemens AG, Merck, Roche, Thermo Fisher Scientific, Bio-Rad, Abbott, Quest Diagnostics, Express Diagnostics Int'l, Psychemedics, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Immunoassay analyzers
      Chromatography instruments
      Breath analyzers
      Others

      Based on the Application:
      Hospitals
      Laboratories
      Workplace
      At-Home

      Buy now